AstraZeneca plc (ADR) (NYSE:AZN)

Top Analyst Upgrades and Downgrades: Alcoa, American Airlines, Equifax, Mindbody, Tiffany, Tyler Technologies and More

Stocks were indicated to open slightly lower this Friday, as a seesaw week comes to an end and new rhetoric from North Korea has hit the tape. The one trend ...
Read Full Story »

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Merrill Lynch recently released its September RIC Report, noting key strategy views and showing many sector views. One such view from the firm was that health care stocks are currently ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

Stocks were looking for direction on Thursday. After a debt ceiling deal was reached on Wednesday, the European Central Bank kept rates flat and maintained an outlook of lower rates ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon, Palo Alto Networks and More

Stocks were indicated to open higher on Friday. The indexes were rising into a three-day weekend and into what will hopefully be the first real round of normalization in Houston and ...
Read Full Story »

Pieris Pharma Soars on AstraZeneca Collaboration

Shares of Pieris Pharmaceuticals Inc. (NASDAQ: PIRS) saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration with AstraZeneca PLC (NYSE: AZN). Specifically, the two ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Canada Goose, Cypress Semi, Ralph Lauren, Sunoco, Tesla, Wells Fargo and Many More

Stocks were indicated marginally higher on Monday, but not with enough of a gain to create any serious expectations for the day. While this bull market in stocks is now more than ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, Apache, Panera, Sunoco, Wal-Mart and Many More

Stocks were indicated to open lower after a weaker than expected payrolls report on Friday. The bull market is now more than eight years old, but investors have shown over ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor, Wynn and More

The futures traded higher Wednesday morning as the market started to look to the first-quarter earnings reports that are set to begin. Most of the pundits on Wall Street are fairly ...
Read Full Story »
Medical vaccine in shoulder, vaccination

Why This FDA Approval for Valeant Is Not as Good as First Thought

Valeant Pharmaceuticals International Inc. (NYSE: VRX) received a key U.S. Food and Drug Administration (FDA) approval early on Thursday, but it seems to be a mixed blessing. Initially shares were higher ...
Read Full Story »
hundred dollar bill

Top 6 Earnings To Watch For On Thursday

Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems the animal spirits powering this rally might not be as ...
Read Full Story »
Stock Price

Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club

December 7, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by more ...
Read Full Story »
Stock Price

FitBit, Teva Slide into Monday’s 52-Week Low Club

December 2, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Stock Price

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
ThinkstockPhotos-475180302

Top 10 Earnings Coming This Week

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. Earnings season is starting to wind down, as most of ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »